Loading…
Lobbying Spend
—
Filings
64
Firms Hired
1
Active Period
2011–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medical Foods and Formulas Access Act of 2025
2026 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 5684
Prior Authorization Reform for Autoimmune and Blood Disorders Act
2026 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 9192
Medical Foods and Formulas Access Act of 2025
2026 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Prior Authorization Reform for Autoimmune and Blood Disorders Act (H.R. 9192) which applies to ERISA / self-funded plans. Requires health plans to honor prior authorization for autoimmune and blood disorder treatments for a 12-month period.
Client expense: — · Firm income: $25,500
Matched citations: S.3304
Medical Foods and Formulas Access Act of 2025
2026 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Pediatric indications for biologic products to treat inflammatory bowel disease
Client expense: — · Firm income: $25,500
Matched citations: H.R. 5684
Medical Foods and Formulas Access Act of 2025
2026 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Pediatric indications for biologic products to treat inflammatory bowel disease
Client expense: — · Firm income: $25,500
Matched citations: S.3304
Medical Foods and Formulas Access Act of 2025
2025 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Client expense: — · Firm income: $25,500
Matched citations: H.R. 5684
Cure Hepatitis C Act of 2025
2025 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Client expense: — · Firm income: $25,500
Matched citations: S. 1941
Medical Foods and Formulas Access Act of 2025
2025 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684, S.3304) Support the Cure Hepatitis C Act (S. 1941) Pediatric indications for biologic products to treat inflammatory bowel disease
Client expense: — · Firm income: $25,500
Matched citations: S.3304
Medical Foods and Formulas Access Act of 2025
2025 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684) Support the Cure Hepatitis C Act (S. 1941) Support Colorados Medicaid State Plan Amendment to allow dispensing fees for the preparation and dispensing of parenteral nutrition as approved by the Colorado General Assembly and signed into law [SB 25-084].
Client expense: — · Firm income: $25,500
Matched citations: H.R. 5684
Cure Hepatitis C Act of 2025
2025 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support the Medical Foods and Formulas Access Act (H.R. 5684) Support the Cure Hepatitis C Act (S. 1941) Support Colorados Medicaid State Plan Amendment to allow dispensing fees for the preparation and dispensing of parenteral nutrition as approved by the Colorado General Assembly and signed into law [SB 25-084].
Client expense: — · Firm income: $25,500
Matched citations: S. 1941
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for those with gastrointestinal and metabolic disorders (no specific legislation) Oppose policies to the Children's Health Insurance Program and Medicaid that would lead to loss of coverage and access to care (H.R. 1)
Client expense: — · Firm income: $25,500
Matched citations: H.R. 1
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Client expense: — · Firm income: $25,500
Matched citations: H.R. 2630
Medical Nutrition Equity Act of 2023
2024 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Client expense: — · Firm income: $25,500
Matched citations: H.R. 6892
Biosimilar Red Tape Elimination Act
2024 · fourth_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Client expense: — · Firm income: $25,500
Matched citations: S. 2305
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products. Oppose Biosimilar Red Tape Elimination Act (S. 2305) Improve pediatric indications for biologics (no specific legislation)
Client expense: — · Firm income: $25,500
Matched citations: S. 652
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 2630
Medical Nutrition Equity Act of 2023
2024 · third_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 6892
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans. Generally support pediatric access to biologic therapies and caution against removing interchangeability and biosimilar distinction among biological products.
Client expense: — · Firm income: $25,500
Matched citations: S. 652
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 2630
Supporting Community Lenders Act
2024 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support legislation to ban the sale of water beads, Ban Water Beads Act (H.R. 6486); Esther's Law (S. 4298)
Client expense: — · Firm income: $25,500
Matched citations: H.R. 6486
Medical Nutrition Equity Act of 2023
2024 · second_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 6892
Support legislation to ban the sale of water beads, Ban Water Beads Act (H.R. 6486); Esther's Law (S. 4298)
Client expense: — · Firm income: $25,500
Matched citations: S. 4298
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: — · Firm income: $25,500
Matched citations: S. 652
Access to medically necessary foods and formulas for patients with gastrointestinal disorders and covered by Medicaid, CHIP, FEHBP or private health insurance plans; Medical Nutrition Equity Act (H.R. 6892) Support the Safe Step Act (S. 652 / H.R. 2630) which provides exceptions to step therapy protocols for ERISA health plans.
Client expense: — · Firm income: $25,500
Matched citations: H.R. 2630
Supporting Community Lenders Act
2024 · first_quarter · Firm: SUMMIT HEALTH CARE CONSULTING
Support legislation to ban the sale of water beads, Ban Water Beads Act (H.R. 6486); no specific legislation 1st Quarter 2024
Client expense: — · Firm income: $25,500
Matched citations: H.R. 6486
Source: Senate LDA